Maintenance With Selinexor/Placebo After Combination Chemotherapy in Participants With Endometrial Cancer [SIENDO] (ENGOT-EN5)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03555422 |
|
Recruitment Status :
Active, not recruiting
First Posted : June 13, 2018
Last Update Posted : December 5, 2023
|
Sponsor:
Karyopharm Therapeutics Inc
Collaborators:
Belgium and Luxembourg Gynaecological Oncology Group
North-Eastern German Society of Gynaecologic Oncology
Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies
Spanish Research Group in Ovarian Cancer
The Central and Eastern European Gynecologic Oncology Group
Israel Society of Gynecologic Oncology
The GOG Foundation, Inc.
Information provided by (Responsible Party):
Karyopharm Therapeutics Inc
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | December 2024 |
| Estimated Study Completion Date : | December 2024 |